• Molecular NameDromostanolone
  • Synonym2M-DHTP; 2MDTP; Blackburn Compound; Dromostanolone propionate; Dromostanolone proprionate; Drostanolone; Drostanolone propionate; MDHT; Medrotestron propionate
  • Weight304.474
  • Drugbank_IDDB00858
  • ACS_NO58-19-5
  • Show 3D model
  • LogP (experiment)3.99
  • LogP (predicted, AB/LogP v2.0)3.89
  • pkaN/A
  • LogD (pH=7, predicted)3.89
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-4.75
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors1
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds0
  • TPSA37.3
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn anabolic steroid. Its main medical applications are to lower cholesterol levels, and as an antineoplastic agent in the treatment of some cancers.
  • Absorption_valueN/A
  • Absorption (description)Well absorbed following parenteral administration.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySide effects include virilization (masculine traits in women), acne, fluid retention, and hypercalcemia.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A